No Detail Found!

Efficacy of the Labetalol Versus Methyldopa in Pregnancy Induced Hypertension Among Patients Visiting Tertiary Care Hospital

Author(s)
Hajira Khalid gynecologist, Sindh Government Qatar Hospital Karachi, Pakistan
Fozia Parveen Gynae and OBS, Dow University of Health Sciences, Karachi, Pakistan
Amina Begum gynecologist, CDF Hospital Hyderabad, Pakistan
Aksa Ismail gynecologist, DHQ Hospital Dadu, Pakistan
Sadia Detho gynecologist, Dow University of Health Sciences, Karachi, Pakistan
Ulvina Khalid gynecologist, Dow University of Health Sciences, Karachi, Pakistan
Abstract
Objective: To compare the mean arterial pressure of labetalol versus methyldopa in pregnancy induced hypertension in patients Methodology: This randomized control trial was done at Gynae unit I civil Hospital Karachi from Jan 2017 to Feb 2018. Women were randomly allocated into two groups, in which 97 women were treated with labetalol and 97 were treated with methyldopa. Outcome was measured in the form of efficacy of the drug by lowering systolic blood pressure less than 140 mmHg and diastolic less than 90 mmHg up to 7 days after starting treatment. Results: The average age of the patients was 30.14±4.84 years. MAP was significantly better in those women who were treated with labetalol as compared to methyldopa [92.85±8.95 vs. 99.58±7.73 p=0.0005]. Effectiveness was significantly high in labetalol as compare to methyldopa [91.8% vs. 62.9% p=0.0005] Conclusion: The present study confirms that labetalol is an effective drug for use and quicker in achieving adequate control of blood pressure in pregnancy-induced hypertension
Publication Details
Page(s) 131-134
DOI DOI not available
Published Journal: Journal of Society of Obstetricians and gynaecologists of Pakistan, Volume: 11, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
methyldopa, Pregnancy induced hypertension, Labetalol, Hypertensive disorder
0

Citations

0

Downloads

41

Views